诚信认证：
工商注册信息已核实！
快速导航
产品分类
微信二维码
Minisite
QQ号咨询
脂类
N-myristoyl-D-erythro-sphingosine
| 品牌 | 厂商性质 | 产地 | 货期 |
|---|---|---|---|
| 阿拉丁 | 生产商 | 上海 | 现货 |
产品参数
| 货号 | CAS号 | 操作 |
|---|---|---|
| N130619-100mg | 123408-74-2 | 询价 |
| N130619-25mg | 123408-74-2 | 询价 |
| N130619-5mg | 123408-74-2 | 询价 |
产品介绍
属性
| 存贮条件 | 储存温度 -20°C |
描述
| 应用 |
C14 Ceramide (d18:1/14:0) is suitable for use · as a standard in high-performance liquid chromatography/tandem mass spectrometry (LC/MS2) for ceramide quantification from muscel biopsies · in lipid monolayer preparation for biophysical studies · in the morphological and dimensional evaluation studies |
| 产品介绍 | Ceramide synthesis is majorly driven by de novo pathway involving the palmitoyl-CoA and L-serine, and also by salvage pathway via recycling of complex sphingolipids. The ceramide transporter, Cert mediates the transfer of C14 from smooth endoplasmic reticulum to Golgi. Ceramide synthase CerS6 enzyme is involved in the synthesis of C14 ceramide |
| 生化机理 | Ceramides regulate biological processes including proliferation, differentiation and apoptosis.[6] In the cystic fibrosis patients, elevated levels of C14 ceramide is observed. It is also a potential biomarker for hepatic steatosis (HS) and C14 ceramide levels correlate with the aspartate aminotransferase (AST) / alanine transaminase (ALT) ratio. Tumor necrosis factor α (TNFα) mediates increase in the C14 levels. Fumonisin B1 prevents the C14 accumulation. |
| 别名 | N-(tetradecanoyl)-sphing-4-enine ;C14 Ceramide (d18:1/14:0)； N-myristoyl-D-erythro-sphingosine； (2S,3R,4E)-2-(Myristoylamino)-4-octadecene-1,3-diol, N-Myristoyl-D-erythro-sphingosine, N-Tetradecanoyl-D-sphingosine, N-[(1S,2R,3E)-2-Hydroxy-1-(hydroxymethyl)-3-heptadecen-1-yl]tetradecanamide, C14-Ceramide, Cer(d18:1/14:0)； N-Myristoyl-D-sphingosine |
N-myristoyl-D-erythro-sphingosine信息由上海阿拉丁生化科技股份有限公司为您提供，如您想了解更多关于N-myristoyl-D-erythro-sphingosine报价、型号、参数等信息，欢迎来电或留言咨询。
注：该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案，不可用于临床诊断或治疗等相关用途